Merck KGaA Statistics

Total Valuation

Merck KGaA has a market cap or net worth of EUR 51.20 billion. The enterprise value is 58.50 billion.

Market Cap	51.20B
Enterprise Value	58.50B

Important Dates

The next estimated earnings date is Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.03%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	129.20M

Valuation Ratios

The trailing PE ratio is 18.44.

PE Ratio	18.44
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	11.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.12, with an EV/FCF ratio of 20.28.

EV / Earnings	21.06
EV / Sales	2.76
EV / EBITDA	10.12
EV / EBIT	14.32
EV / FCF	20.28

Financial Position

The company has a current ratio of 1.19, with a Debt / Equity ratio of 0.34.

Current Ratio	1.19
Quick Ratio	0.71
Debt / Equity	0.34
Debt / EBITDA	1.78
Debt / FCF	3.57
Interest Coverage	17.84

Financial Efficiency

Return on equity (ROE) is 9.82% and return on invested capital (ROIC) is 6.63%.

Return on Equity (ROE)	9.82%
Return on Assets (ROA)	5.10%
Return on Invested Capital (ROIC)	6.63%
Return on Capital Employed (ROCE)	10.15%
Revenue Per Employee	358,455
Profits Per Employee	47,052
Employee Count	59,020
Asset Turnover	0.42
Inventory Turnover	1.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.73% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-24.73%
50-Day Moving Average	135.77
200-Day Moving Average	149.75
Relative Strength Index (RSI)	29.33
Average Volume (20 Days)	524

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Merck KGaA had revenue of EUR 21.16 billion and earned 2.78 billion in profits. Earnings per share was 6.39.

Revenue	21.16B
Gross Profit	12.52B
Operating Income	4.09B
Pretax Income	3.54B
Net Income	2.78B
EBITDA	5.78B
EBIT	4.09B
Earnings Per Share (EPS)	6.39

Full Income Statement

Balance Sheet

The company has 3.08 billion in cash and 10.30 billion in debt, giving a net cash position of -7.23 billion.

Cash & Cash Equivalents	3.08B
Total Debt	10.30B
Net Cash	-7.23B
Net Cash Per Share	n/a
Equity (Book Value)	29.99B
Book Value Per Share	68.80
Working Capital	2.16B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.59 billion and capital expenditures -1.70 billion, giving a free cash flow of 2.88 billion.

Operating Cash Flow	4.59B
Capital Expenditures	-1.70B
Free Cash Flow	2.88B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 59.20%, with operating and profit margins of 19.31% and 13.13%.

Gross Margin	59.20%
Operating Margin	19.31%
Pretax Margin	16.72%
Profit Margin	13.13%
EBITDA Margin	27.33%
EBIT Margin	19.31%
FCF Margin	13.63%

Dividends & Yields

This stock pays an annual dividend of 2.20, which amounts to a dividend yield of 1.73%.

Dividend Per Share	2.20
Dividend Yield	1.73%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	37.13%
Buyback Yield	n/a
Shareholder Yield	1.73%
Earnings Yield	5.42%
FCF Yield	5.63%

Dividend Details

Stock Splits

The last stock split was on June 30, 2014. It was a forward split with a ratio of 2.

Last Split Date	Jun 30, 2014
Split Type	Forward
Split Ratio	2

Scores

Merck KGaA has an Altman Z-Score of 3.22.

Altman Z-Score	3.22
Piotroski F-Score	n/a